Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    20688393 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: ara-C;   Biological: gemtuzumab ozogamicin

Study has passed its completion date and status has not been verified in more than two years.